Skip to Content
Merck
CN

720828

Indazole-6-boronic acid

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C7H7BN2O2
CAS Number:
Molecular Weight:
161.95
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352103
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/C7H7BN2O2/c11-8(12)6-2-1-5-4-9-10-7(5)3-6/h1-4,11-12H,(H,9,10)

SMILES string

OB(O)c1ccc2cn[nH]c2c1

InChI key

ZKNLCHWRWRYPGG-UHFFFAOYSA-N

form

solid

mp

112-117 °C

storage temp.

2-8°C

Quality Level

Application

Indazole-6-boronic acid can be used as a reactant:
  • In Suzuki-Miyaura coupling reaction to synthesize indazole derivatives via C-C bond formation by reacting with different aryl halides.
  • To synthesize indazole substituted purines and pyrrolo[2,3-d]pyrimidines as potential kinase inhibitors.

Reactant for preparation of:
  • Bicyclic hydroxyphenylmethanone derivatives as hydroxysteroid dehydrogenase inhibitors
  • Bisphosphonate inhibitors of human farnesyl pyrophosphate synthase
  • Indazolyl benzoimidazoles as PKC-ζ inhibitors
  • Pyrazolopyrimidinamine derivatives and their tyrosine and phosphinositide kinase inhibitory activity

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Design, synthesis, and preclinical evaluation of fused pyrimidine-based hydroxamates for the treatment of hepatocellular carcinoma
Chen D, et al.
Journal of Medicinal Chemistry, 61(4), 1552-1575 (2018)
Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells
Lin Y-S, et al.
Journal of medicinal chemistry, 55(7), 3201-3215 (2012)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service